K2 BioLabsPonce TherapeuticsPortfolioRapha Capital Management Ponce Therapeutics Executes Worldwide Exclusive License to Speratum Biopharma’s Nano-in™ and No-Pass Mimic™ Nanoparticle Technologies in Anti-Aging and Other Products Initially for Skin
K2 BioLabsPonce TherapeuticsPortfolioRapha Capital Management New Biotechnology Research Accelerator Launches in Houston
Ponce TherapeuticsPortfolioRapha Capital Management Ponce Therapeutics Inc. Commences First R & D Program in Anti-Aging Products for Skin
